Ireland: GDPR: Implementing Additional Data Protection Rules In Health Research

Last Updated: 21 September 2018
Article by Rob Corbet
Most Read Contributor in Ireland, October 2018

Data controllers conducting "Health Research" must be conscious of the recent signing of the Data Protection Act 2018 (Section 36(2)) (Health Research) Regulations 2018 (S.I. No. 314/2018), as they introduce material changes to the rules governing how health research can be conducted in Ireland.


The Regulations build on the existing themes of the General Data Protection Regulation (GDPR) and the Data Protection Act 2018, by applying a third layer of specific data protection rules to health research in Ireland.

The mandatory additional requirements for health research were brought about through a consultation process between the Minister for Health and the Data Protection Commission. Significantly, the Regulations were adopted on 8 August 2018, within three months of commencement of the GDPR and the Data Protection Act 2018, illustrating that this is a high priority issue for the government and the Data Protection Commission and likely to be actively enforced.

To the extent that the Regulations are silent on specific aspects of data processing, the GDPR and the Act continue to apply.


Under Article 9(2)(i) of the GDPR the processing of special categories of data (such as data relating to health) for reasons of public interest in the area of public health is subject to "suitable and specific measures" to safeguard the rights and freedoms of data subjects. Similarly under section 42(1) of the Data Protection Act 2018, the processing of personal data for scientific research purposes is subject to "suitable and specific measures being taken to safeguard the fundamental rights and freedoms of data subjects". Section 42(2) goes on to provide that such processing must "respect the principle of data minimisation", while Section 42(3) states that such processing should only identify the data subjects to the extent necessary for the scientific research.

Where scientific research involves the processing of special categories of data (such as data relating to health), Article 9(2) (j) of the GDPR requires that such processing must:

  1. be proportionate to the aim pursued;
  2. respect the essence of the right to data protection; and
  3. provide again for "suitable and specific measures" to safeguard the fundamental rights and interests of the data subject.

The GDPR does not define "suitable and specific measures" but Section 36(1) of the Act partially does. It provides a nonexhaustive list of "suitable and specific measures" that may be adopted by controllers where personal data is being processed for research purposes under Section 42. However, Section 36(2) also provides for further regulations to be made identifying further suitable and specific measures to those listed in Section 36(1) and/or to specify that certain suitable and specific measures be mandatory in some cases.


The GDPR contains a number of provisions that apply to health research. For example, the GDPR provides that processing for scientific research purposes should be "interpreted in a broad manner including for example technological development and demonstration, fundamental research, applied research and privately funded research" (Recital 159 GDPR). In addition, scientific research should be subject to "appropriate safeguards" in respect of "the rights and freedoms of the data subject" under Article 89(1). The Regulations are in effect Ireland's attempt to prescribe "appropriate safeguards" in the specific context of health research.

The broad scope of activities constituting health research is maintained in the Regulations where the term "Health Research" is defined as any of the following scientific research for the purpose of human health:

  1. Research with the goal of understanding the normal and abnormal functioning of the human body;
  2. Research specifically concerned with developing innovative strategies, products or services to diagnose, treat or prevent disease or injury;
  3. Research with the goal of improving the diagnosis, treatment, rehabilitation and palliation of human disease and injury and of improving the health and quality of life of individuals;
  4. Research with the goal of improving the efficiency and effectiveness of health professionals and the health care system; and
  5. Research with the goal of improving the health of the population as a whole or any part of the population through better understanding of social, cultural, environmental, occupational and economic factors on determining health status.

The Regulations also provide that establishing whether a person is suitable for inclusion in each of the foregoing health research activities shall also constitute Health Research.


Regulation 3(1) provides that the obligations under the Regulations only apply to data controllers. Therefore, any research institutions undertaking Health Research as data processors on the instructions of a data controller are not subject to the Regulations. However they do of course remain responsible for compliance with all of the other data processor obligations set out in the GDPR and the Act. Further, given the liability provisions in the GDPR can extend to all controllers and processors involved in the processing in some cases, processors have a vested interest in working closely with their controllers to ensure adherence to the new Regulations. Controllers should also be aware that, insofar as an activity constitutes Health Research, separate EU and national legislation may apply. For example, Recitals 156 and 161 of GDPR and Regulation 15 of the Regulations make it clear that the relevant provisions of the Clinical Trials Regulation (EU) 536/2014 shall also apply when appropriate.


Data controllers engaged in Health Research which involves the processing of any personal data (regardless of whether the data includes individually identifiable health data), are subject to the Regulations and must therefore adopt all of the following suitable and specific measures, as set out in Regulation 3:

  1. Ensure that arrangements are in place to ensure that personal data is processed in a manner that does not cause damage or distress to the data subject or is likely to cause damage or distress to the data subject;
  2. Put appropriate governance structures in place for carrying out Health Research including:
    1. ethical approval of Health Research by a research ethics committee;
    2. specification of the data controllers or processors involved;
    3. compliance with Article 26 of the GDPR if there are joint controllers;
    4. specification of persons with whom it is intended to share personal data even where that data is pseudonymised or anonymised (and the purpose of such sharing);
    5. specification of funders or persons supporting the Health Research project;
    6. provision of training in data protection law and practice to those carrying out the Health Research;
  3. Ensure the following processes and procedures relating to the management and conduct of Health Research are in place;
    1. assessment of the data protection implications of Health Research. If this assessment indicates a high risk to rights and freedoms of individuals, a data protection impact assessment ("DPIA") must be carried out (which in turn must follow the requirements of Articles 35 and 36 of the GDPR);
    2. compliance with the "data minimisation" principle in Article 5(1)(c) of the GDPR;
    3. controls to limit access to the personal data undergoing processing in order to prevent unauthorised consultation, alteration, disclosure or erasure of personal data;
    4. controls to log whether and by whom personal data have been consulted, altered, disclosed or erased;
    5. measures to protect the security of the personal data concerned;
    6. arrangements to anonymise, archive or destroy personal data once Health Research is completed; and
    7. other technical and organisational measures to ensure data processing is GDPR-compliant, together with processes for testing and evaluating the effectiveness of such measures.
  4. Identify and put in place arrangements to ensure personal data is processed in a transparent manner; and
  5. Obtain "Explicit Consent" from the data subject prior to commencement of the Health Research.


Pursuant to the GDPR definition of "consent" and the guidance provided by the Article 29 Working Party, "explicit consent" is an express statement of consent, usually obtained via a written record, which is freely given, specific, informed, unambiguous and capable of withdrawal at any time. Explicit consent is one of the main lawful bases that can support the processing of special categories of personal data under Article 9 of GDPR. Under the strict terms of the GDPR, explicit consent is not required if one of the other Article 9 grounds is satisfied, such as Article 9(2)(j), where processing is necessary for health research purposes. However, the Regulations provide that when processing personal data for purposes of Health Research, the explicit consent of the data subject must be obtained in addition to the other suitable and specific measures detailed above.

This is probably the most important change introduced by the Regulations. Traditionally many research institutions would rely solely on informed consent to justify health research, albeit they would apply appropriate safeguards to the data, such as anonymization, IT security measures etc to comply in broad terms with data protection laws. The Regulations now embed a list of very specific suitable and specific measures all of which must be applied to all Health Research projects and these apply in addition to the underlying obligation to obtain explicit consent.


Under the Regulations, controllers may seek an exception from the requirement to seek explicit consent via a declaration from a Committee (appointed by the Minister for Health) that the public interest in carrying out this research significantly outweighs the public interest in requiring the explicit consent of the data subject (a "Committee Declaration"). However, obtaining a Committee Declaration is a very involved process which is set out in detail in Regulations 5 and 6 of the Regulations.

The relevant steps to take advantage of this exception are dependent on whether the Health Research commenced on, before or after 8 August 2018.


To seek an exemption in relation to new Health Research activity, the applicant controller must convince the Committee that the public interest is significantly weighted in favour of proceeding with the health research over requiring the explicit consent of the data subject. At a minimum, the application must confirm that a DPIA has been carried out and that ethical approval has been obtained for the health research from a research ethics committee. In addition, Regulation 5(4) sets out a detailed list of additional information that must be provided in support of an application for a Committee Declaration (See Appendix).

Note that the Committee Declaration, if granted, only removes the requirement for the explicit consent of the data subject. All other suitable and specific measures, as set out above, must still be in place in all cases.


A slightly different test for a Committee Declaration applies where the relevant Health Research commenced prior to 8 August 2018, but the controller processes or further processes personal data after this date. In these circumstances, the controller must either:

  1. obtain explicit consent of data subject as soon as practicable and no later than 30 April 2019; or
  2. apply for a Committee Declaration that explicit consent from the data subject is not required as:

a. the public interest in carrying out the health research significantly outweighs the public interest in requiring consent of the data subject; or

b. the controller had previously obtained the data subject's consent to their personal data being processed for health research purposes in accordance with the old data protection regime (Data Protection Directive 95/46/EC and the Data Protection Acts 1988 and 2003) and this consent has not been withdrawn. In this circumstance, the controller is required to provide written information to Committee stating that they made reasonable efforts to contact data subject seeking to re-obtain their consent.

In addition to carrying out a DPIA, the controller must also fulfil the same conditions as apply to new Health Research projects carried out on or after 8 August 2018 (see Appendix).


Irrespective of when the relevant Health Research commenced, the Committee has authority to either make a Committee Declaration, with or without conditions, or to refuse the application. The Committee may also revoke a declaration where it is satisfied that the conditions imposed by the Committee have not been met.

Committee Declarations, as well as any appeals against these decisions, will be published on the Committee's website.


The Regulations are silent on the sanctions faced by a controller for any breaches of the Regulations. However, pursuant to Articles 82 and 83 of the GDPR and Part 6 of the Act, the full suite of enforcement measures and rights of redress for data subjects under the GDPR and the Act shall apply for breaches of the Regulations. These include the wellpublicised GDPR fines of up to €20 million or 4% of worldwide annual turnover as well as rights for data subjects to sue, regardless of whether or not they suffer material damage.


For both existing and future Health Research projects, the Regulations emphasise the importance of having informed consent forms in place which meet all of the transparency and consent criteria under the GDPR. In addition, the governance and management of Health Research projects should be reviewed to ensure they meet the new standard of "suitable and specific measures" laid out in the Regulations. All controllers engaged in Health Research in Ireland should therefore review their processing activities against the requirements of the Regulations and, if necessary, consider whether an application for an exception to the explicit consent condition should be made to the new Committee.


Application for a Committee Declaration

The application must satisfy each of the following conditions:

  1. Written confirmation that clearly identifies the lawful basis for processing personal data under Article 6 of the GDPR (usually consent or legitimate interests) and identify that the controller has met one of the conditions under Article 9(2) regarding processing of special categories of personal data (usually Scientific Research Purposes under Article 9(2)(j)).
  2. Written confirmation that clearly identifies the controller or joint controllers and their division of responsibilities.
  3. Written information demonstrating that:
    1. This Health Research requires personal data of the type specified to be obtained and processed rather than anonymised data;
    2. Processing of personal data will not cause, or is likely to cause, any damage or distress to the data subject;
    3. Personal data will only be collected and used as necessary for research objective;
    4. Personal data will not be disclosed without explicit consent to the disclosure by the data subject or as required by law;
    5. Suitable and specific measures are in place prior to commencement of health research;
    6. A data protection officer has been appointed in relation to the health research; and
    7. Ethical approval from research ethics committee has been received.

The application must also attach a copy of the DPIA with particular reference to possibility of data linkages if necessary and details of consultations with potential data subjects and written information demonstrating that public interest in carrying out health research significantly outweighs the public interest in requiring explicit consent of the data subject, together with a statement setting out reasons why it is not proposed to seek the data subject's consent. (In the case of applications relating to existing health research projects which are based on consent, written information is required demonstrating that the controller has made reasonable efforts to contact the data subject who previously provided their consent in accordance with the pre-GDPR data protection regime for the purposes of reobtaining consent from that data subject).

This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Ronan Daly Jermyn
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Ronan Daly Jermyn
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions